Positive results from phase III ZENITH study of Winrevair (sotatercept-csrk) in adults with pulmonary arterial hypertension – Merck Inc
Merck Inc.,( known as MSD outside of the United States and Canada), announced positive topline results from the Phase III ZENITH study evaluating Winrevair (sotatercept-csrk) in adults with… read more.
